VCs scout opportunities in MedTech despite higher valuation fueled by pandemic

A growing population of more than 600 million with a combined GDP of more than $3 trillion and a rapid growth of the middle class are expected to fuel strong demand in healthcare coverage in Southeast Asia.

MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline

Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.

Daiwa VC fund manager DCI Partners launches $135M fund to accelerate drug discovery

Tokyo-based DCI Partners, a venture fund manager of Daiwa Securities Group, has announced the launch of Daiwa Taiwan-Japan BioVenture Investment Limited Partnership II, a $135 million (JPY 14 billion) investment fund intended for drug discovery.


In Singapore, AI helps cancer patients find clinical trials

Next, the startup is expanding across Southeast Asia.